219 related articles for article (PubMed ID: 38691546)
1. The importance of variant reinterpretation in inherited cardiovascular diseases: Establishing the optimal timeframe.
Fernandez-Falgueras A; Coll M; Iglesias A; Tiron C; Campuzano O; Brugada R
PLoS One; 2024; 19(5):e0297914. PubMed ID: 38691546
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
[TBL] [Abstract][Full Text] [Related]
3. [Why do we need genetics in cardiac rhythmology?].
Rieder M; Castiglione A; Asatryan B; Odening KE
Herzschrittmacherther Elektrophysiol; 2020 Dec; 31(4):394-400. PubMed ID: 32661562
[TBL] [Abstract][Full Text] [Related]
4. Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms.
Barriales-Villa R; Gimeno-Blanes JR; Zorio-Grima E; Ripoll-Vera T; Evangelista-Masip A; Moya-Mitjans A; Serratosa-Fernández L; Albert-Brotons DC; García-Pinilla JM; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):300-9. PubMed ID: 26856793
[TBL] [Abstract][Full Text] [Related]
5. Channelopathies, genetic testing and risk stratification.
Wilde AAM; Amin A
Int J Cardiol; 2017 Jun; 237():53-55. PubMed ID: 28343764
[TBL] [Abstract][Full Text] [Related]
6. The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases.
Mazzanti A; O'Rourke S; Ng K; Miceli C; Borio G; Curcio A; Esposito F; Napolitano C; Priori SG
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):499-519. PubMed ID: 24650315
[TBL] [Abstract][Full Text] [Related]
7. Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience.
Mak CM; Chen SP; Mok NS; Siu WK; Lee HH; Ching CK; Tsui PT; Fong NC; Yuen YP; Poon WT; Law CY; Chong YK; Chan YW; Yung TC; Fan KY; Lam CW
Hong Kong Med J; 2018 Aug; 24(4):340-349. PubMed ID: 29497013
[TBL] [Abstract][Full Text] [Related]
8. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Ackerman MJ; Priori SG; Willems S; Berul C; Brugada R; Calkins H; Camm AJ; Ellinor PT; Gollob M; Hamilton R; Hershberger RE; Judge DP; Le Marec H; McKenna WJ; Schulze-Bahr E; Semsarian C; Towbin JA; Watkins H; Wilde A; Wolpert C; Zipes DP
Heart Rhythm; 2011 Aug; 8(8):1308-39. PubMed ID: 21787999
[No Abstract] [Full Text] [Related]
9. The electrocardiographic abnormalities in highly trained athletes compared to the genetic study related to causes of unexpected sudden cardiac death.
Macarie C; Stoian I; Dermengiu D; Barbarii L; Piser IT; Chioncel O; Carp A; Stoian I
J Med Life; 2009; 2(4):361-72. PubMed ID: 20108749
[TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
Napolitano C; Bloise R; Monteforte N; Priori SG
Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
[No Abstract] [Full Text] [Related]
11. Impact of genetics on the clinical management of channelopathies.
Schwartz PJ; Ackerman MJ; George AL; Wilde AAM
J Am Coll Cardiol; 2013 Jul; 62(3):169-180. PubMed ID: 23684683
[TBL] [Abstract][Full Text] [Related]
12. Genetics and arrhythmias: diagnostic and prognostic applications.
Monteforte N; Napolitano C; Priori SG
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):278-86. PubMed ID: 22245453
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac ion channelopathies: A potential link between cardiomyopathies and cardiac arrhythmias].
Schimpf R; Rudic B; Tülümen E; Papavassiliu T; Dösch C; Borggrefe M
Dtsch Med Wochenschr; 2013 Mar; 138(12):591-7. PubMed ID: 23483420
[No Abstract] [Full Text] [Related]
14. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.
Bai R; Napolitano C; Bloise R; Monteforte N; Priori SG
Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):6-15. PubMed ID: 19808439
[TBL] [Abstract][Full Text] [Related]
15. Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing.
Louis C; Calamaro E; Vinocur JM
Curr Opin Cardiol; 2018 Jan; 33(1):78-86. PubMed ID: 29059074
[TBL] [Abstract][Full Text] [Related]
16. Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue.
Ackerman MJ
Heart Rhythm; 2015 Nov; 12(11):2325-31. PubMed ID: 26144349
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for inherited cardiac arrhythmias.
Fowler SJ; Cerrone M; Napolitano C; Priori SG
Hellenic J Cardiol; 2010; 51(2):92-103. PubMed ID: 20378510
[No Abstract] [Full Text] [Related]
18. [Recognizing rare cardiac diseases by electrocardiogram].
Grimm W; Grimm A; Grimm K; Efimova E
Internist (Berl); 2018 Jun; 59(6):618-629. PubMed ID: 29619572
[TBL] [Abstract][Full Text] [Related]
19. [Sudden cardiac death in athletes with an apparently normal heart: the channelopathies].
Giustetto C; Gaita F
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):78S-82S. PubMed ID: 19195312
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.
Tester DJ; Ackerman MJ
Circulation; 2011 Mar; 123(9):1021-37. PubMed ID: 21382904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
